| 变应原疫苗对变态反应性鼻炎、支气管哮喘患者血清中TIgE及IgG水平的影响 |
| |
| 引用本文： | 刘光辉,王忠喜,黄爱霞,祝戎飞,李文静,张威,陈欢. 变应原疫苗对变态反应性鼻炎、支气管哮喘患者血清中TIgE及IgG水平的影响[J]. 药物流行病学杂志, 2004, 13(4): 175-177 |
| |
| 作者姓名： | 刘光辉 王忠喜 黄爱霞 祝戎飞 李文静 张威 陈欢 |
| |
| 作者单位： | 华中科技大学同济医学院附属同济医院变态反应科,武汉,430030 |
| |
| 摘 要： | 目的 :观察变应原疫苗 (阿罗格 NHD)对变态反应性鼻炎、支气管哮喘患者血清TIgE及IgG水平的影响。方法 :采用自身前后对照方法 ,比较鼻炎组和哮喘组在阿罗格脱敏治疗前后血清TIgE及IgG水平的变化。结果 :鼻炎组治疗前后TIgE为 (783.5 0± 2 7.80 )IU/mL及 (32 4 .33± 10 .30 )IU/mL ,IgG为 (7.82± 0 .91) g/L及(14 .32± 0 .82 ) g/L ;变态反应性哮喘组治疗前后TIgE为 (80 3.5 0± 2 8.30 )IU/mL及 (332 .4 8± 11.2 0 )IU/mL ,IgG为 (7.78± 0 .96 ) g/L及 (13.4 8± 0 .88) g/L ;均具统计学意义 (P <0 .0 1)。结论 :阿罗格 NHD能降低变态反应性鼻炎和变态反应性哮喘患者血清TIgE水平、提高血清IgG水平 ,是治疗变态反应性鼻炎和变态反应性哮喘的有效药物
|
| 关 键 词： | 疫苗／变应原 鼻炎，变态反应性 哮喘／支气管 |
| 文章编号： | 1005-0698(2004)04-0175-03 |
The Serum TIgE and IgG Level in Allergic Rhinitis and Allergic Asthma Patients with Treatment of Allergic Vaccine NHD |
| |
| Liu Guanghui,Wang Zhongxi,Huang Aixi,Zhu RongfeiLi Wenjing,Zhang Wei,Chen HuanAllergy Department,Tongji Hospital,Tongji Medical College,Huazhong Universityof Science and Technology,Wuhan,P.R.China. The Serum TIgE and IgG Level in Allergic Rhinitis and Allergic Asthma Patients with Treatment of Allergic Vaccine NHD[J]. Chinese Journal of Pharmacoepidemiology, 2004, 13(4): 175-177 |
| |
| Authors: | Liu Guanghui Wang Zhongxi Huang Aixi Zhu RongfeiLi Wenjing Zhang Wei Chen HuanAllergy Department Tongji Hospital Tongji Medical College Huazhong Universityof Science Technology Wuhan P.R.China |
| |
| Affiliation: | Liu Guanghui,Wang Zhongxi,Huang Aixia,Zhu RongfeiLi Wenjing,Zhang Wei,Chen HuanAllergy Department,Tongji Hospital,Tongji Medical College,Huazhong Universityof Science and Technology,Wuhan 430030,P.R.China |
| |
| Abstract: | |
| |
| Keywords: | Allergic vaccine Allergic rhinitis Allergic asthma |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
